Histidine-rich glycoprotein (HRG) Tokushima 2: Novel HRG deficiency, molecular and cellular characterization

Thrombosis and Haemostasis

Volumn 84, Issue 4, 2000, Pages 675-679

  Shigekiyo, T ^a   Yoshida, H ^a   Kanagawa, Y ^a   Satoh, K ^a   Wakabayashi, S ^a   Matsumoto, T ^a   Koide, T ^a  

^a TOKUSHIMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Congenital histidine rich glycoprotein deficiency; Histidine rich glycoprotein; Thrombosis

Indexed keywords

ARGININE; CARBOHYDRATE; CYSTATIN; GLYCOPROTEIN; HISTIDINE;

AGED; ARTERIOVENOUS FISTULA; ARTICLE; BLOOD LEVEL; CASE REPORT; CELL MUTANT; CELL STRUCTURE; CONGENITAL DISORDER OF GLYCOSYLATION; CONTROLLED STUDY; FAMILIAL INCIDENCE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MORPHOLOGY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; THROMBOSIS;

EID: 0033782662     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614086     Document Type: Article

References (37)

1. 2 glycoprotein (CM protein I)
2. Amino acid sequence of human histidine-rich glycoprotein derived from the nucleotide of its cDNA
3. Structural characterization of the gene for human histidine-rich glycoprotein. Reinvestigation of the 5'-terminal region of cDNA and search for the liver specific promotor in the gene
4. Evidence for the absence of intron H of the histidine-rich glycoprotein (HRG) gene: Genetic mapping and in situ localization of HRG to chromosome 3q28-29
5. Histidine-rich glycoprotein is present in human platelets and is released following thrombin stimulation
6. Turnover of histidine-rich glycoprotein during heparin administration in man
7. Human serum histidine-rich glycoprotein. I. Interaction with heme, metal ions and organic ligands
8. Heparin binding properties of human histidine-rich glycoprotein. Mechanism and role in the neutralization of heparin in plasma
9. Interaction of histidine-rich glycoprotein with fibrinogen and fibrin
10. Bovine histidine-rich glycoprotein is a substrate for bovine plasma factor XIIIa
11. Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein
12. Complex formation of platelet thrombospondin with histidine-rich glycoprotein
13. Regulation of complement functional efficiency by histidine-rich glycoprotein
14. Histidine-rich glycoprotein binding to activated human platelets
15. Interaction of histidine-rich glycoprotein with human T lymphocytes
16. Histidine-rich glycoprotein: An abundant plasma protein in search of a function
17. Histidine-rich glycoprotein: Is there a role in hemostasis or immune function?
18. Congenital histidine-rich glycoprotein deficiency
19. HRG Tokushima: Molecular and cellular characterization of histidine-rich glycoprotein (HRG) deficiency
20. A new case of hereditary histidine-rich glycoprotein deficiency with familial thrombophilia
21. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies
22. Histidine-rich glycoprotein in a normal and a clinical population
23. Identification and genetic analysis of a common molecular variant of histidine-rich glycoprotein with a difference of 2KD in apparent molecular weight
24. An amino acid polymorphism in histidine-rich glycoprotein (HRG) explains 59% of the variance in plasma HRG levels
25. Fistulas and vascular malformations of the dura and dural sinuses
26. Carotid-cavernous fistulas and intracavernous aneurysms
27. Inherited thrombophilia: Pathogenesis, clinical syndromes, and management
28. Activation of immobilized plasminogen by tissue activator. Multimolecular Complex Formation
29. Acceleration of plasminogen activation by tissue plasminogen activator on surface-bound histidine-proline-rich glycoprotein
30. Determination of the disulphide bridge arrangement of bovine histidine-rich glycoprotein
31. Domain structure and conformation of histidine-proline-rich glycoprotein
32. Degradation of CFTR by the ubiquitin-proteasome pathway
33. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction
34. Lactacystin, an inhibitor of the proteasome, blocks the degradation of a mutant precursor of glycosylphosphatidylinositol-linked protein in a pre-Golgi
35. Proteasome-dependent endoplasmic reticulum-associated protein degradation: An unconventional route to a familiar fate
36. Intracellular degradation of secretion defect-type mutants of antithrombin is inhibited by proteasomal inhibitors
37. Warfarin causes the degradation of protein C precursor in the endoplasmic reticulum